TRADING
ECONOMICS
CALENDAR
INDICATORS
Countries
Indicators
MARKETS
Currencies
Stocks
Commodities
Bonds
Earnings
FORECASTS
Countries
Indicators
Currencies
Stocks
Commodities
Bonds
APPS
DATA
Download historical data for 20 million indicators using your browser.
Already a user? Login
API GATEWAY
Direct access to our calendar releases and historical data from your apps.
ALERTS
Receive releases for indicators in your mail inbox and set alerts for markets.
ESTIMATES
Join the world's largest survey of market forecasts and estimates for indicators.
IECONOMICS
Intelligent search to get instant answers with data and charts.
UECONOMICS
Drag & drop charts and store your calendar preferences in a dashboard.
Angola - Hospital beds
Hospital beds (per 1,000 people) in Angola was reported at 0.8 in 2005, according to the World Bank collection of development indicators, compiled from officially recognized sources.
Historical
Data
API
1Y
5Y
10Y
MAX
Column
Line
Area
Spline
Splinearea
Candlestick
Bars
Trend
Average(4)
Histogram
Variance
Mean
Maximum
Minimum
Export Data
API Access
OK
<iframe src='https://tradingeconomics.com/embed/?s=ago.sh.med.beds.zs%3aworldbank&lbl=0&v=201804300000v&h=300&w=600&ref=/angola/hospital-beds-per-1-000-people-wb-data.html' height='300' width='600' frameborder='0' scrolling='no'></iframe><br />source: <a href='https://tradingeconomics.com/angola/hospital-beds-per-1-000-people-wb-data.html'>tradingeconomics.com</a>
width
height
Preview
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.
Learn More
Register
Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.
Learn More
Interested?
Click here to contact us
Hospital beds include inpatient beds available in public, private, general, and specialized hospitals and rehabilitation centers. In most cases beds for both acute and chronic care are included.
Angola | Health
Ratio of school attendance of orphans to school attendance of non-orphans ages 10-14
0.85
15.2
%
10.5
%
14.5
%
16.3
%
25.2
%
11.5
%
43.8
%
39.2
%
30.1
%
27.9
%
23.6
%
70.8
%
57.8
%
50.6
%
48.7
%
37.7
%
79.7
%
69.5
%
63.1
%
61.4
%
47.8
%
41.4
%
43.8
%
34.3
%
23.2
%
16.5
%
85.8
%
75
%
69.6
%
68.7
%
57.5
%
Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age)
7.6
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
47.7
%
Prevalence of anemia among children (% of children under 5)
50.9
%
Prevalence of anemia among non-pregnant women (% of women ages 15-49)
47.2
%
28.7
%
52.8
%
13352
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total)
61.8
%
Number of infant deaths
64595
Cause of death, by injury (% of total)
10.7
%
Number of under-five deaths
95905
Cause of death, by non-communicable diseases (% of total)
27.4
%
Number of neonatal deaths
35332
15.4
Adults (ages 15+) living with HIV
260000
Persons
AIDS estimated deaths (UNAIDS estimates)
11000
Female adults with HIV (% of population ages 15+ with HIV)
59.71
%
Prevalence of HIV, total (% of population ages 15-49)
1.9
%
Mortality rate, under-5 (per 1,000)
82.5
Mortality rate, under-5, female (per 1,000 live births)
76.4
Mortality rate, under-5, male (per 1,000 live births)
88.2
Under-5 mortality rate (per 1,000 live births): Q1 (lowest)
102
Under-5 mortality rate (per 1,000 live births): Q2
103
Under-5 mortality rate (per 1,000 live births): Q3
73
Under-5 mortality rate (per 1,000 live births): Q4
66
Under-5 mortality rate (per 1,000 live births): Q5 (highest)
39
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70
25
%
Mortality rate; neonatal (per 1;000 live births)
29.3
19.7
19.2
19.1
19.2
20.5
20.3
19.6
19.7
20.5
22.5
16
16
16.6
16.7
17.5
3.7
%
10.5
%
24.6
%
34.5
%
44.4
%
31.2
%
27.2
%
31.2
%
32.7
%
33.5
%
Median birth interval (months): Q1 (lowest)
28.4
Median birth interval (months): Q2
28.9
Median birth interval (months): Q3
30.5
Median birth interval (months): Q4
34.5
Median birth interval (months): Q5 (highest)
39.9
0.6
%
1.4
%
7.8
%
12.6
%
23.4
%
15.2
%
13.09
%
Children (0-14) living with HIV
23000
Persons
Prevalence of HIV, female (% ages 15-24)
0.8
%
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)
32.5
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)
31.6
Prevalence of HIV, male (% ages 15-24)
0.4
%
Antiretroviral therapy coverage (% of people with advanced HIV infection)
22
%
AIDS deaths in adults and children (high estimate)
16000
AIDS deaths in adults and children (low estimate)
7700
AIDS deaths in adults and children
11000
Adults (ages 15+) newly infected with HIV
21000
Children (ages 0-14) newly infected with HIV
3600
Adults (ages 15+) and children (ages 0-14) newly infected with HIV
25000
Incidence of HIV (% of uninfected population ages 15-49)
0.17
%
31.7
%
35.3
%
Children orphaned by HIV/AIDS
130000
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
44
%
Adults (ages 15+) and children (0-14 years) living with HIV
280000
Persons
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 (lowest)
20.4
%
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2
18.3
%
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3
28.4
%
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4
28.1
%
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 (highest)
34.7
%
Immunization, Hib3 (% of children ages 12-23 months)
64
%
Immunization, BCG (% of one-year-old children)
58
%
Vaccinations (BCG) (% of children ages 12-23 months): Q1 (lowest)
53.9
%
Vaccinations (BCG) (% of children ages 12-23 months): Q2
56.7
%
Vaccinations (BCG) (% of children ages 12-23 months): Q3
73.4
%
Vaccinations (BCG) (% of children ages 12-23 months): Q4
70.1
%
Vaccinations (BCG) (% of children ages 12-23 months): Q5 (highest)
83.6
%
Immunization, DPT (% of children ages 12-23 months)
64
%
Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 (lowest)
23.1
%
Vaccinations (DPT 3) (% of children ages 12-23 months): Q2
23.4
%
Vaccinations (DPT 3) (% of children ages 12-23 months): Q3
34.4
%
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4
36.4
%
Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 (highest)
47.3
%
Immunization, measles (% of children ages 12-23 months)
49
%
Vaccinations (Measles) (% of children ages 12-23 months): Q1 (lowest)
37.8
%
Vaccinations (Measles) (% of children ages 12-23 months): Q2
43.7
%
Vaccinations (Measles) (% of children ages 12-23 months): Q3
56.2
%
Vaccinations (Measles) (% of children ages 12-23 months): Q4
55.2
%
Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest)
68.2
%
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q1 (lowest)
14.9
%
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q2
17.9
%
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3
13.7
%
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q4
10.5
%
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q5 (highest)
8.3
%
Immunization, Pol3 (% of one-year-old children)
66
%
Hospital beds
0.8
Nurses and midwives
1.44
Physicians
0.144
Deaths among children under five years of age due to malaria
8.3
%
Reported malaria deaths (total)
6909
Notified cases of malaria (per 100;000 people)
21593
Mosquito net use by children (any mosquito net) (% of children under 5): Q1 (lowest)
18.4
%
Mosquito net use by children (any mosquito net) (% of children under 5): Q2
27
%
Mosquito net use by children (any mosquito net) (% of children under 5): Q3
29.1
%
Mosquito net use by children (any mosquito net) (% of children under 5): Q4
28.4
%
Mosquito net use by children (any mosquito net) (% of children under 5): Q5 (highest)
26.6
%
Household posession of mosquito nets (any type of mosquito net) (% of households): Q1 (lowest)
31.3
%
Household posession of mosquito nets (any type of mosquito net) (% of households): Q2
39.5
%
Household posession of mosquito nets (any type of mosquito net) (% of households): Q3
42.2
%
Household posession of mosquito nets (any type of mosquito net) (% of households): Q4
38.7
%
Household posession of mosquito nets (any type of mosquito net) (% of households): Q5 (highest)
32.7
%
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q1 (lowest)
20.5
%
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q2
39.5
%
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q3
35
%
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q4
20.8
%
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q5 (highest)
20.9
%
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q2
23.1
%
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q3
23.9
%
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q4
23
%
Household posession of mosquito nets (insecticide-treated net) (% of households): Q1 (lowest)
27.5
%
Household posession of mosquito nets (insecticide-treated net) (% of households): Q2
33.8
%
Household posession of mosquito nets (insecticide-treated net) (% of households): Q3
34.8
%
Household posession of mosquito nets (insecticide-treated net) (% of households): Q4
30.7
%
Household posession of mosquito nets (insecticide-treated net) (% of households): Q5 (highest)
26.9
%
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q1 (lowest)
18.3
%
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q2
33.7
%
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q3
27.4
%
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q4
15.3
%
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q5 (highest)
15.9
%
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q1 (lowest)
29.1
%
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q2
54.7
%
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q3
75
%
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q4
78.9
%
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q5 (highest)
79.2
%
Use of Intermittent Preventive Treatment of malaria, 2+ doses of SP/Fansidar (% of pregnant women)
17.5
%
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q1 (lowest)
19.1
%
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q2
31.2
%
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q3
44.1
%
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q4
48.2
%
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q5 (highest)
58.5
%
Treatment of fever (% of children under 5 with fever): Q1 (lowest)
15.3
%
Treatment of fever (% of children under 5 with fever): Q2
17.8
%
Treatment of fever (% of children under 5 with fever): Q3
17.5
%
Treatment of fever (% of children under 5 with fever): Q4
19.3
%
Treatment of fever (% of children under 5 with fever): Q5 (highest)
23.4
%
Children with fever receiving antimalarial drugs (% of children under age 5 with fever)
28.3
%
Number of maternal mortality deaths
5400
Lifetime risk of maternal death (1 in: rate varies by country)
32
Lifetime risk of maternal death
3.08
%
Prevalence of anemia among pregnant women
50.8
%
3.8
%
2.7
%
1.3
%
1.2
%
1.3
%
Risk of catastrophic expenditure for surgical care (% of people at risk)
51.4
%
Risk of impoverishing expenditure for surgical care (% of people at risk)
55.5
%
48.4
%
63.6
%
80.5
%
90.6
%
94.9
%
Pregnant women receiving prenatal care of at least four visits (% of pregnant women)
31.5
%
Antenatal care (any skilled personnel) (% of women with a birth): Q1 (lowest)
56.6
%
Antenatal care (any skilled personnel) (% of women with a birth): Q2
72.1
%
Antenatal care (any skilled personnel) (% of women with a birth): Q3
89.4
%
Antenatal care (any skilled personnel) (% of women with a birth): Q4
96.1
%
Antenatal care (any skilled personnel) (% of women with a birth): Q5 (highest)
97.9
%
Pregnant women receiving prenatal care
79.8
%
Antenatal care (doctor) (% of women with a birth): Q1 (lowest)
3.4
%
Antenatal care (doctor) (% of women with a birth): Q2
7.7
%
Antenatal care (doctor) (% of women with a birth): Q3
15
%
Antenatal care (doctor) (% of women with a birth): Q4
22.3
%
Antenatal care (doctor) (% of women with a birth): Q5 (highest)
30.6
%
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q1 (lowest)
25.2
%
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q2
45.4
%
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q3
46.8
%
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q4
66.4
%
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q5 (highest)
77.9
%
ARI treatment (% of children under 5 taken to a health provider)
58
%
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q1 (lowest)
3.6
%
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q2
3
%
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q3
3.5
%
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q4
3.1
%
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q5 (highest)
3.2
%
Exclusive breastfeeding (% of children under 6 months)
11
%
Assistance during delivery (any skilled personnel) (% of births): Q1 (lowest)
18.9
%
Assistance during delivery (any skilled personnel) (% of births): Q2
29.5
%
Assistance during delivery (any skilled personnel) (% of births): Q3
58.6
%
Assistance during delivery (any skilled personnel) (% of births): Q4
76.8
%
Assistance during delivery (any skilled personnel) (% of births): Q5 (highest)
89.3
%
Births attended by skilled health staff (% of total)
47.3
%
Place of delivery (births at health facility) (% of births): Q1 (lowest)
13.2
%
Place of delivery (births at health facility) (% of births): Q2
24.9
%
Place of delivery (births at health facility) (% of births): Q3
55.7
%
Place of delivery (births at health facility) (% of births): Q4
74
%
Place of delivery (births at health facility) (% of births): Q5 (highest)
86.1
%
Assistance during delivery (doctor) (% of births): Q1 (lowest)
1.2
%
Assistance during delivery (doctor) (% of births): Q2
3.3
%
Assistance during delivery (doctor) (% of births): Q3
6.3
%
Assistance during delivery (doctor) (% of births): Q4
11.2
%
Assistance during delivery (doctor) (% of births): Q5 (highest)
23.5
%
Low-birthweight babies (% of births)
12
%
Prevalence of diarrhea (% of children under 5): Q1 (lowest)
18.6
%
Prevalence of diarrhea (% of children under 5): Q2
20.4
%
Prevalence of diarrhea (% of children under 5): Q3
20.1
%
Prevalence of diarrhea (% of children under 5): Q4
21.9
%
Prevalence of diarrhea (% of children under 5): Q5 (highest)
22.2
%
Prevalence of children with fever (% of children under 5): Q1 (lowest)
16.3
%
Prevalence of children with fever (% of children under 5): Q2
16.3
%
Prevalence of children with fever (% of children under 5): Q3
13.4
%
Prevalence of children with fever (% of children under 5): Q4
13.7
%
Prevalence of children with fever (% of children under 5): Q5 (highest)
12.5
%
Prevalence of underweight, weight for age, female (% of children under 5)
14.6
%
Prevalence of underweight, weight for age, male (% of children under 5)
16.6
%
26.9
%
22.4
%
17.1
%
12.1
%
7.8
%
Malnutrition prevalence, weight for age (% of children under 5)
15.6
%
Malaria cases reported
2769305
8.5
%
6.1
%
4.7
%
2.2
%
1.4
%
Maternal mortality ratio (modeled estimate, per 100,000 live births)
477
Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding)
31.7
%
64.1
%
53.5
%
40.4
%
43.3
%
28.3
%
60.2
%
56.5
%
69.6
%
79.1
%
89.7
%
31.1
%
37.9
%
53.2
%
44.4
%
57.3
%
Diarrhea treatment (% of children under 5 who received ORS packet)
34.9
%
Prevalence of overweight, female (% of female adults)
34.9
%
Prevalence of overweight, male (% of male adults)
19.5
%
Prevalence of overweight, weight for height, female (% of children under 5)
5.5
%
Prevalence of overweight, weight for height, male (% of children under 5)
5.1
%
Prevalence of overweight (% of children under 5)
5.3
%
23.6
%
17.9
%
13.7
%
8.7
%
7
%
Prevalence of stunting, height for age, female (% of children under 5)
26.1
%
Prevalence of stunting, height for age, male (% of children under 5)
32.4
%
47.3
%
45.1
%
38.8
%
26.6
%
20.4
%
Malnutrition prevalence, height for age (% of children under 5)
29.2
%
Mortality caused by road traffic injury (per 100,000 people)
24.4
Prevalence of wasting, weight for height, female (% of children under 5)
8.1
%
Prevalence of wasting, weight for height, male (% of children under 5)
8.2
%
5.6
%
5.3
%
4.9
%
4.1
%
3.6
%
Prevalence of wasting (% of children under 5)
8.2
%
1.3
%
1.5
%
1
%
0.6
%
0.1
%
Prevalence of severe wasting, weight for height, female (% of children under 5)
4.2
%
Prevalence of severe wasting, weight for height, male (% of children under 5)
4.3
%
Prevalence of severe wasting, weight for height (% of children under 5)
4.3
%
Tuberculosis treatment success rate (% of registered cases)
34
%
Tuberculosis case detection rate (all forms)
56
%
Incidence of tuberculosis (per 100,000 people)
370
Tuberculosis death rate (per 100,000 people)
64
Deaths due to tuberculosis among HIV-negative people, high uncertainty bound (per 100,000 population)
66
Deaths due to tuberculosis among HIV-negative people, low uncertainty bound (per 100,000 population)
17
278000
%
1.28
%
0.0436
437000
0.0147
%
2.01
%
0.0141
555000
0.00773
%
2.55
%
2694000
%
12.38
%
988000
%
4.54
%
1699000
%
7.81
%
36
35.3
%
43.3
%
59.8
%
68.5
%
77
%
Newborns protected against tetanus
78
%
External resources for health (% of total expenditure on health)
2.63
%
Out-of-pocket health expenditure (% of total expenditure on health)
23.96
%
Out-of-pocket health expenditure (% of private expenditure on health)
67.04
%
Health expenditure per capita
179
USD
Health expenditure per capita, PPP (constant 2005 international $)
239
Health expenditure, private (% of GDP)
1.18
%
Health expenditure, public (% of total health expenditure)
64.26
%
Health expenditure, public (% of government expenditure)
5
%
Health expenditure, public (% of GDP)
2.12
%
Health expenditure, total (% of GDP)
3.31
%
Number of people who are undernourished
3500000
Depth of the food deficit (kilocalories per person per day)
90
Depth of hunger (kilocalories per person per day)
320
Consumption of iodized salt (% of households)
44.7
%
Vitamin A supplements for postpartum women (% of women with a birth): Q1 (lowest)
18.7
%
Vitamin A supplements for postpartum women (% of women with a birth): Q2
23.4
%
Vitamin A supplements for postpartum women (% of women with a birth): Q3
30.9
%
Vitamin A supplements for postpartum women (% of women with a birth): Q4
27.5
%
Vitamin A supplements for postpartum women (% of women with a birth): Q5 (highest)
26.1
%
Vitamin A supplements for children (% of children ages 6-59 months): Q1 (lowest)
3
%
Vitamin A supplements for children (% of children ages 6-59 months): Q2
3.3
%
Vitamin A supplements for children (% of children ages 6-59 months): Q3
4.9
%
Vitamin A supplements for children (% of children ages 6-59 months): Q4
7.2
%
Vitamin A supplements for children (% of children ages 6-59 months): Q5 (highest)
12.9
%
Vitamin A supplementation coverage rate (% of children ages 6-59 months)
6
%
Adolescent fertility rate (births per 1,000 women ages 15-19)
162
Mortality rate, adult, female (per 1,000 female adults)
206
Mortality rate, adult, male (per 1,000 male adults)
280
Birth rate, crude
42.32
Death rate, crude
8.68
Mean number of children ever born to women aged 40-49: Q1 (lowest)
7
Mean number of children ever born to women aged 40-49: Q2
7.3
Mean number of children ever born to women aged 40-49: Q3
6.9
Mean number of children ever born to women aged 40-49: Q4
6.4
Mean number of children ever born to women aged 40-49: Q5 (highest)
5.5
Current use of contraception (modern method) (% of married women): Q1 (lowest)
1
%
Current use of contraception (modern method) (% of married women): Q2
2.6
%
Current use of contraception (modern method) (% of married women): Q3
8.9
%
Current use of contraception (modern method) (% of married women): Q4
18.5
%
Current use of contraception (modern method) (% of married women): Q5 (highest)
30.7
%
Contraceptive prevalence, modern methods (% of women ages 15-49)
4.8
%
Current use of contraception (any method) (% of married women): Q1 (lowest)
1.3
%
Current use of contraception (any method) (% of married women): Q2
3.3
%
Current use of contraception (any method) (% of married women): Q3
9.8
%
Current use of contraception (any method) (% of married women): Q4
20.2
%
Current use of contraception (any method) (% of married women): Q5 (highest)
32.6
%
Contraceptive prevalence (% of women ages 15-49)
17.7
%
Mortality rate, infant, female (per 1,000 live births)
49
Mortality rate, infant (per 1,000 live births)
54.6
Mortality rate, infant, male (per 1,000 live births)
60
Infant mortality rate (per 1,000 live births): Q1 (lowest)
62
Infant mortality rate (per 1,000 live births): Q2
64
Infant mortality rate (per 1,000 live births): Q3
47
Infant mortality rate (per 1,000 live births): Q4
43
Infant mortality rate (per 1,000 live births): Q5 (highest)
25
Life expectancy at birth, female (years)
64.09
years
Life expectancy at birth, total (years)
61.19
years
Life expectancy at birth, male (years)
58.42
years
Fertility rate, total (births per woman)
5.77
Total fertility rate (TFR) (births per woman): Q1 (lowest)
8.5
Total fertility rate (TFR) (births per woman): Q2
8.2
Total fertility rate (TFR) (births per woman): Q3
6.8
Total fertility rate (TFR) (births per woman): Q4
4.7
Total fertility rate (TFR) (births per woman): Q5 (highest)
4
Survival to age 65, female (% of cohort)
65.39
%
Survival to age 65, male (% of cohort)
55.42
%
7.4
7.2
5.4
3.9
3.3
Female headed households (% of households with a female head)
34.5
%
30.3
%
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q1 (lowest)
47.8
%
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q2
58.2
%
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q3
41.4
%
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q4
25.3
%
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q5 (highest)
15.9
%
Teenage mothers (% of women ages 15-19 who have had children or are currently pregnant)
42.5
%
Completeness of birth registration, rural
25.8
%
Completeness of birth registration, urban
39.9
%
Completeness of birth registration
35.6
%
12.5
%
11.7
%
13.3
%
12.4
%
9.8
%
22.2
%
28.1
%
32
%
26.5
%
21
%
34.7
%
39.7
%
45.3
%
38.9
%
30.7
%
Related
Angola Inflation Rate Edges Up in July
Angola Cuts Key Interest Rate
Angola Inflation Rate Slightly Down
Angola Leaves Rates on Hold
Angola Inflation Rate Down to Record Low
Angola Raises Liquidity Absorption Facility
Angola Inflation Rate Slows in April
Angola Leaves Monetary Policy Unchanged
Angolan Inflation Rate Down To 7.32% in March
Angola Leaves Key Rate on Hold; Changes Lending and Absorption Facility Rates
Angola Inflation Rate Decelerates
Angola Holds Key Rate Steady
Angola Inflation Rate Accelerates in January
National Bank of Angola Leaves Rate Unchanged at 9.25%
Angola Inflation Rate at 7.69% in December
National Bank of Angola Leaves Monetary Policy Unchanged
Angola Inflation Rate Slows Even Further in November
National Bank of Angola Cuts Rate by 50 bps
Angolan Inflation Rate Down to Record Low in October
National Bank of Angola Leaves Rates On Hold
Latest
Singapore Inflation Rate Slows to 0.2% in March
Week Ahead
Canada Inflation Rate Rises to 2.3%, Highest Since October 2014
Spain Trade Deficit Narrows 16.8% in February
Japan Inflation Rate at 3-Month Low of 1.1 % in March
Indonesia Leaves Monetary Policy Unchanged
US Initial Claims Decline to 232K in Latest Week
Hong Kong Jobless Rate Lowest Since 1998
Australia Jobless Rate Steady at 5.5% in March
New Zealand Inflation Slows Further in Q1
Canada Leaves Key Rate Steady at 1.25%
Russia Jobless Rate Drops to 5% in March as Expected
Eurozone March Inflation Rate Revised Lower to 1.3%
UK Inflation Rate Eases to a Year-Low in March
South Africa Inflation Rate Lowest Since 2011
Malaysia Inflation Rate at 20-Month Low of 1.3% in March
Japan Posts Largest Trade Surplus in Over a Year
US March Industrial Output Growth Stronger than Expected
US Housing Starts Rise 1.9% in March
Italy February Trade Surplus Widens More than Expected
Angola
United States
United Kingdom
Euro area
China
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia
Botswana
Brazil
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Channel Islands
Chile
China
Colombia
Comoros
Congo
Costa Rica
Cote d Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Asia and Pacific
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Euro area
European Union
Europe and Central Asia
Faeroe Islands
Fiji
Finland
France
French Polynesia
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Greenland
Grenada
Guam
Guatemala
Guinea
Guinea Bissau
Guyana
Haiti
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
North Korea
Norway
Oman
Pakistan
Palau
Panama
Palestine
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Republic of the Congo
Romania
Russia
Rwanda
Samoa
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Asia
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor Leste
Togo
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Yemen
Zambia
Zimbabwe
Calendar
Forecast
Indicators
News
Blog
Markets
Currency
GDP
GDP
GDP Annual Growth Rate
GDP From Agriculture
GDP From Construction
GDP From Manufacturing
Gdp From Mining
Gdp From Public Administration
Gdp From Services
Gdp From Transport
Gdp From Utilities
GDP per capita
GDP per capita PPP
Labour
Living Wage Family
Living Wage Individual
Minimum Wages
Population
Unemployment Rate
Wages High Skilled
Wages Low Skilled
Prices
Consumer Price Index CPI
CPI Transportation
Food Inflation
Inflation Rate
Inflation Rate Mom
Producer Prices
Producer Prices Change
Money
Central Bank Balance Sheet
Deposit Interest Rate
Foreign Exchange Reserves
Interbank Rate
Interest Rate
Lending Rate
Loans To Banks
Loans To Private Sector
Money Supply M0
Money Supply M1
Money Supply M2
Money Supply M3
Trade
Balance of Trade
Capital Flows
Crude Oil Production
Current Account
Current Account to GDP
Exports
Exports by Category
Exports by Country
External Debt
Foreign Direct Investment
Gold Reserves
Imports
Imports by Category
Imports by Country
Terrorism Index
Government
Credit Rating
Fiscal Expenditure
Government Budget
Government Budget Value
Government Debt to GDP
Government Revenues
Government Spending
Holidays
Military Expenditure
Business
Business Confidence
Competitiveness Index
Competitiveness Rank
Corruption Index
Corruption Rank
Ease of Doing Business
Industrial Production
Industrial Production Mom
Internet Speed
IP Addresses
Manufacturing Production
Mining Production
Consumer
Bank Lending Rate
Taxes
Corporate Tax Rate
Personal Income Tax Rate
Sales Tax Rate
Social Security Rate
Social Security Rate For Companies
Social Security Rate For Employees
Climate
Precipitation
Temperature
TRADING
ECONOMICS
20M INDICATORS
50K MARKETS
196 COUNTRIES
HISTORICAL DATA
INDICATORS
ECONOMIC CALENDAR
FOREX
LIVE QUOTES
STOCKS
FORECASTS
COMMODITIES
RATINGS
BONDS
GET STARTED
Like this page? Share it
Facebook
Twitter
Google+
LinkedIn
TRADING ECONOMICS supports the UN Refugee Agency
DONATE